|
⚲
|
| Keyboard |
| NB Alternatives Advisers LLC
✚
|
|
|---|---|
| CRD # | 149822 |
| SEC # | 801-70009 |
| CIK # | 0001469000 |
| AUM | 160.24 B (2026-03-27) |
| Employees | 417 (54% Investors, 41% Brokers) |
| Fees | |
| Minimum | |
| Phone | 214-647-9500 |
| Address | 325 North Saint Paul Street Dallas, TX 75201 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Nvidia Corp | 5.1 | ||
| Microsoft Corp | 4.2 | ||
| Apple Inc | 4.0 | ||
| Amazon Com Inc | 3.6 | ||
| Alphabet Inc | 2.7 | ||
| Alphabet Inc | 2.5 | ||
| J P Morgan Chase & Co | 2.3 | ||
| Lilly Eli & Co | 1.6 | ||
| Facebook Inc | 1.4 | ||
| Broadcom Inc | 1.3 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | ARS IX SH RT | 2026-03-27 | ||
| PE | Bloom I Co-Investment LP | 2026-03-27 | 643.5 M | |
| PE | NB Blueprint 2025 Direct Investment HoldCo LP | 2026-03-27 | 1,484.7 M | |
| PE | NB Brilliance Aggregator LP | 2026-03-27 | 134.4 M | |
| PE | NB Secondary Opportunities Fund VI LP | 2026-03-27 | 2,333.1 M | |
| PE | NB Select OPPS VIII MHF LP | 2026-03-27 | ||
| PE | NB Strategic Capital II Co-Invest LP | 2026-03-27 | 44.6 M | |
| PE | Neuberger TRIA Aggregator LP | 2026-03-27 | 28.0 M | |
| PE | Almanac Realty Securities X LP | 2025-03-28 | ||
| PE | Almanac Realty Securities X Parallel LP | 2025-03-28 | ||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 2 | 0.5 |
| (c) Banking or thrift institutions | 28 | 11.9 |
| (d) Investment companies | 16 | 4.2 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 192 | 89.1 |
| (g) Pension and profit sharing plans | 48 | 22.9 |
| (h) Charitable organizations | 4 | 0.5 |
| (i) State or municipal government entities | 9 | 7.9 |
| (j) Other investment advisers | 4 | 0.5 |
| (k) Insurance companies | 61 | 20.0 |
| (l) Sovereign wealth funds and foreign official institutions | 9 | 1.4 |
| (m) Corporations or other businesses not listed above | 6 | 1.4 |
| (n) Other | 0 | 0.0 |
| Total | 379 | 160.2 |
| By Discretionary | ||
| Discretionary | 336 | 141.7 |
| Non-Discretionary | 43 | 18.6 |
| Total | 379 | 160.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 29.8 | |
| United States Persons | 130.4 | |
| Total | 379 | 160.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Justin Hakimian | Executive Officer | 12 | 4 | |
| NB Alternatives Advisers LLC | Executive Officer | 53 | 3 | |
| Matthew Kaplan | Executive Officer | 51 | 3 | |
| Henry Herms | Executive Officer | 29 | 3 | |
| Andrew Silberstein | Executive Officer | 18 | 3 | |
| D Aloian | Executive Officer | 16 | 3 | |
| Jennifer Cattier | Executive Officer | 12 | 3 | |
| David Haltiner | Executive Officer | 9 | 2 | |
| Manuela Amado Cattaneo | Executive Officer | 9 | 2 | |
| John McGurk | Executive Officer | 8 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001469000] | |
| 3 | [0001469000] | |
| 4 | [0001469000] | |
| SC 13D | [0001469000] | |
| SC 13G | [0001469000] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $4.4B |
| Clients | 15 (12 non-US) |
| Serves | Institutional, Research |
| Fund Types | Hedge Fund, Private Equity |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Solo Brands Inc DTC
Class A Common Stock
|
2023-05-16 | Sell | 4,181,906 | $5.00 | 20,909,530 |
|
Solo Brands Inc DTC
Class A Common Stock
|
2023-05-16 | Sell | 2,073,689 | $5.00 | 10,368,445 |
|
Biora Therapeutics Inc PROG
Warrant · derivative
|
2021-06-14 | Buy | 8,097,166 | $2.47 | 20,000,000 |
|
Biora Therapeutics Inc PROG
Common Stock
|
2021-06-14 | Buy | 8,097,166 | $2.47 | 20,000,000 |
|
Biora Therapeutics Inc PROG
Common Stock
|
2021-06-01 | Buy | 961,807 | $2.86 | 2,750,768 |
|
Biora Therapeutics Inc PROG
Common Stock
|
2021-06-01 | Buy | 306,308 | $2.86 | 876,041 |
|
SolarWinds Corp SWI
Common Stock
|
2020-12-10 | Sell | 289,066 | $21.97 | 6,350,780 |
|
Biora Therapeutics Inc PROG
7.25% Convertible Senior Notes due 2025 · derivative
|
2020-12-07 | Buy | 78,500,000 | $78,500,000.00 | 6,162,250,000,000,000 |
|
Biora Therapeutics Inc PROG
Common Stock
|
2020-12-07 | Buy | 4,128,440 | $3.27 | 13,499,999 |
|
Biora Therapeutics Inc PROG
7.25% Convertible Senior Notes due 2025 · derivative
|
2020-12-07 | Buy | 25,000,000 | $25,000,000.00 | 625,000,000,000,000 |
|
Biora Therapeutics Inc PROG
Unsecured Convertible Promissory Note · derivative
|
2020-06-23 | Conversion | 101,736,263 | ||
|
Biora Therapeutics Inc PROG
Series B Preferred Stock · derivative
|
2020-06-23 | Conversion | |||
|
Biora Therapeutics Inc PROG
Common Stock
|
2020-06-23 | Conversion | 18,319,853 | ||
|
Biora Therapeutics Inc PROG
Common Stock
|
2020-06-23 | Buy | 3,333,333 | $15.00 | 49,999,995 |
|
Biora Therapeutics Inc PROG
Common Stock
|
2020-06-23 | Conversion | 1,250,000 | ||
|
SolarWinds Corp SWI
Common Stock
|
2019-05-28 | Sell | 302,419 | $17.42 | 5,268,139 |
|
SolarWinds Corp SWI
Common Stock
|
2018-10-23 | Conversion | 3,561,571 | ||
|
SolarWinds Corp SWI
Class A Common Stock · derivative
|
2018-10-23 | Conversion | 53,292 |
| Comparable Firms | State | AUM |
|---|---|---|
|
KKR Credit Advisors US LLC
✚
|
CA | 270.85 B |
|
Churchill Asset Management LLC
✚
|
NY | 55.66 B |
|
Leucadia Asset Management LLC
✚
|
NY | 3,056.3 M |
|
Generative Investment Partners LP
✚
|
CT | 293.9 M |
|
Marshall Wace LLP
✚
|
||
|
The Northern Trust Company of Connecticut
✚
|
CT | |
|
MC Asset Management Holdings LLC
✚
|
CT |